Predicting circulating CA125 levels among healthy premenopausal women

<p><strong>Background:</strong> Cancer antigen 125 (CA125) is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, this has not been well de...

Full description

Bibliographic Details
Main Authors:	Sasamoto, N, Babic, A, Rosner, BA, Fortner, RT, Vitonis, AF, Yamamoto, HS, Fichorova, RN, Tjonneland, A, Hansen, L, Overvad, K, Kvaskoff, M, Fournier, A, Mancini, F, Boeing, H, Trichopoulou, A, Peppa, E, Karakatsani, A, Palli, D, Pala, V, Mattiello, A, Tumino, R, Grasso, CC, Onland-Moret, NC, Weiderpass, E, Quirós, JR, Lujan-Barroso, L, Rodríguez-Barranco, M, Colorado-Yohar, S, Barricarte, A, Dorronsoro, M, Idahl, A, Lundin, EA, Sartor, H, Khaw, K-T, Key, TJ, Muller, DC, Riboli, E, Gunter, MJ, Dossus, L, Kaaks, R, Cramer, DW, Tworoger, SS, Terry, KL
Format:	Journal article
Language:	English
Published:	American Association for Cancer Research 2019

Predicting circulating CA125 levels among healthy premenopausal women

Similar Items